XTLB Stock Summary and Trading Ideas (XTL Biopharmaceuticals Ltd. - American Depositary Shares | NASDAQ:XTLB)

XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.

XTL Biopharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol XTLB.

As of October 26, 2026, XTLB stock price was flat at $2.02 with 301 million shares trading.

XTLB has a beta of 1.22, meaning it tends to be more sensitive to market movements. XTLB has a correlation of 0.02 to the broad based SPY ETF.

XTLB has a market cap of $4.96 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XTLB traded as high as $19.96 and as low as $1.78.

XTLB has underperformed the market in the last year with a return of -59.3%, while the SPY ETF gained +15.1%. In the last 3 month period, XTLB fell short of the market, returning -30.3%, while SPY returned +4.0%. However, in the most recent 2 weeks XTLB has outperformed the stock market by returning +2.0%, while SPY returned -1.7%.

XTLB support price is $1.87 and resistance is $2.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XTLB shares will trade within this expected range on the day.